HLA-C and neoplasm: PLT have been found to protect tumor cells from NK cells, and this effect is mainly due to the transfer of PLT-derived MHC CLASS I molecules to tumor cells after the interaction between PLT and tumor cells, which reduces the anti-tumor reactivity of NK cells and thus avoids immune surveillance (Placke et al., 2012).